|
Gastrointestinal Diseases
Citations 211-220 of 279 total displayed.
|
Past content
(since Jul 1998):
|
- Original Contributions
A Founder Mutation of the MSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States
- Henry T. Lynch; Stephanie M. Coronel; Ross Okimoto; Heather Hampel; Kevin Sweet; Jane F. Lynch; Ali Barrows; Juul Wijnen; Heleen van der Klift; Patrick Franken; Anja Wagner; Riccardo Fodde; Albert de la Chapelle
JAMA 2004; 291: 718-724.
[Abstract]
[Full text]
[PDF]
- Original Contributions
C-Reactive Protein and the Risk of Incident Colorectal Cancer
- Thomas P. Erlinger; Elizabeth A. Platz; Nader Rifai; Kathy J. Helzlsouer
JAMA 2004; 291: 585-590.
[Abstract]
[Full text]
[PDF]
- Editorials
Is C-Reactive Protein an Inflammation Opsonin That Signals Colon Cancer Risk?
- Boris Pasche; Charles N. Serhan
JAMA 2004; 291: 623-624.
[Extract]
[Full text]
[PDF]
- Original Contributions
Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals
- David A. Lieberman; Sheila Prindiville; David G. Weiss; Walter Willett
JAMA 2003; 290: 2959-2967.
[Abstract]
[Full text]
[PDF]
- Clinical Investigations
Association of the Cyclin D1 A870G Polymorphism With Advanced Colorectal Cancer
- Loïc Le Marchand; Ann Seifried; Annette Lum-Jones; Timothy Donlon; Lynne R. Wilkens
JAMA 2003; 290: 2843-2848.
[Abstract]
[Full text]
[PDF]
- Letters
Optimal Intervals and Techniques for Screening Sigmoidoscopy
- Amnon Sonnenberg; David Lieberman
JAMA 2003; 290: 2122-a-2123-a.
[Extract]
[Full text]
[PDF]
- Letters
Optimal Intervals and Techniques for Screening Sigmoidoscopy
- Ishay Lev; Amnon Lahad; Ariae Ben-Yehuda
JAMA 2003; 290: 2122.
[Extract]
[Full text]
[PDF]
- Letters
Optimal Intervals and Techniques for Screening Sigmoidoscopy—Reply
- Robert E. Schoen; Joel L. Weissfeld
JAMA 2003; 290: 2123-a.
[Extract]
[Full text]
[PDF]
- Letters
Optimal Intervals and Techniques for Screening Sigmoidoscopy
- Richard C. Wender
JAMA 2003; 290: 2123.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effect of an Oral Shiga Toxin–Binding Agent on Diarrhea-Associated Hemolytic Uremic Syndrome in Children: A Randomized Controlled Trial
- Howard Trachtman; Avital Cnaan; Erica Christen; Kathleen Gibbs; Sanyi Zhao; David W. K. Acheson; Robert Weiss; Frederick J. Kaskel; Adrian Spitzer; Gladys H. Hirschman
JAMA 2003; 290: 1337-1344.
[Abstract]
[Full text]
[PDF]
|
|
